In a decision that may ripple through the landscape of whistleblower lawsuits, a federal district court in Florida has recently deemed the qui tam provision of the False Claims Act (FCA) unconstitutional. This provision allows private citizens, known as relators, to file lawsuits on behalf of the federal government. The court held that this arrangement is in conflict with the Appointments Clause in Article II of the Constitution, which mandates that the president appoint all federal officers. The district court judge’s decision indicates that relators act as de facto officers of the government by pursuing legal actions against private parties, an appointment that does not receive presidential approval. Details of this ruling can be explored further in this report.
The case in question, United States ex rel. Zafirov v. Florida Medical Associates, marks a potential turning point for the FCA’s whistleblower mechanism and has already been appealed to the Eleventh Circuit. The decision’s constitutional rationale is aligned with a dissent by U.S. Supreme Court Justice Clarence Thomas from last year in US ex rel. Polansky v. Executive Health Resources. In his dissent, Justice Thomas hinted that relators’ actions might be constitutionally dubious, identifying this area of law as a “constitutional twilight zone.” More on Justice Thomas’s influence on this issue is available here.
Over recent years, the Supreme Court, led in part by Justice Thomas’s opinions, has frequently addressed the FCA. Notably, in the 2023 case US ex rel. Schutte v. SuperValu, Thomas reframed the aggressive nature of the scienter requirement in fraud claims, emphasizing a subjective rather than an objective standard. This decision reflects ongoing adjustments in FCA case law, with implications for how fraud claims are prosecuted. For those detailing the current state of the legal landscape, the complete decision can be found here.
Going forward, the appeal of the Zafirov decision will be closely watched by legal professionals and government compliance specialists. Should the Eleventh Circuit uphold the district court’s decision, the issue may well advance to the Supreme Court, potentially altering the future trajectory of whistleblower claims under the FCA. For the legal community, these developments indicate a period of uncertainty and adjustment, particularly for those involved in government compliance and health-care fraud investigations. To gain deeper insights into the case, the docket and more details are available here.